Skip to content

MANAGEMENT OF NADIVRANA WITH SPECIAL REFERENCE TO PILONIDAL SINUS BY TWO TYPES OF VARTIS.

A Comparative Clinical Study on Efficacy of Snuhyadi Varti and Apamarga Kshara Sutra Varti in Management of Nadivrana with Special Reference to Pilonidal Sinus.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044894
Enrollment
100
Registered
2022-08-24
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L059- Pilonidal cyst and sinus without abscess

Interventions

None listed

Sponsors

Dr Prasadshakti G Gannur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with classical signs and symtoms of nadivrana pain,discharge and a sinus in intergluteal region. 2. The age group between 16-60yrs 3. Both gender.

Exclusion criteria

Exclusion criteria: 1. Congenital sinus 2. Pilonidal sinus with systemic diseas DM,Bleedig disorder, AIDS,Tuberculosis Actinomycosis. 3. Osteomyelitis followed by sinus 4. Patient having Neoplastic Sinus 5. If the sinus tract is more than10 cm

Design outcomes

Primary

MeasureTime frame
ASSESSMENT CRITERIA: Subjective parameters. 1 Pain-is asseed on visual analog scale. 2 Burning sensation 3 Itching sensation. Objective parameters 4 Discharge 5 Induration 6 Length of the tract Timepoint: Patient is assessed for above said parameters on 6th weeks. The observations will be recorded in the proforma of case sheet. Management is terminated after 6 weeks of the commencement of the therapy and to check the recurrence of the disease 3 months follow up will be done fortnightly.

Secondary

MeasureTime frame
Incidence of the Patients with classical signs and symtoms of nadivrana (pilonidal sinus) in the OPD and IPD section at SRHI J G COOPERATIVE HOSPITAL SOCIETYS AYURVEDIC MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE will be Discussed with the points related with the Age, Sex, Occupation, Diet, etc.Timepoint: Patient is assessed for above said parameters on every 7th day during treatment schedule ,up to 6 weeks. The observations will be recorded in the proforma of case sheet. Management is terminated after 6 weeks of the commencement of the therapy and to check the recurrence of the disease 3 months follow up will be done fortnightly.

Countries

India

Contacts

Public ContactDr Prasadshakti G Gannur

RGUHS, Karnataka.

nhkshara@gmail.com9449188822

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026